[Microecological aspects of small intestinal bacterial overgrowth syndrome]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|December 14, 2006
PubMed

Insights

Small intestinal bacterial overgrowth syndrome (SIBOS) involves excessive bacteria in the small intestine, leading to malabsorption and infection risks. Diagnosis uses breath tests or aspirate cultures, with treatment involving probiotics and antibiotics.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Internal Medicine

Context:

  • Small intestinal bacterial overgrowth syndrome (SIBOS) is characterized by chronic diarrhea, malabsorption, and increased infection risk.
  • Elevated bacterial counts (>10^5 CFU/ml in adults, >10^4 CFU/ml in children) and diverse microbial species in the small intestine define SIBOS.
  • SIBOS represents a significant disturbance of intestinal microflora, often termed dysbacteriosis.

Purpose:

  • To define Small Intestinal Bacterial Overgrowth Syndrome (SIBOS) and its associated clinical and microbiological features.
  • To outline diagnostic methods for SIBOS, including hydrogen breath testing and direct small intestine aspirate analysis.
  • To describe the comprehensive treatment strategies for SIBOS, encompassing probiotics and antimicrobial agents.

Summary:

  • SIBOS presents with malabsorption, intoxication, and heightened risk of endogenous infection due to increased bacterial load in the small intestine.
  • Microecological shifts in SIBOS can lead to B12 deficiency anemia, hypovitaminosis, protein deficiency, bacterial translocation, endotoxinemia, and potential infection generalization.
  • Diagnostic approaches include lactulose breath tests measuring hydrogen concentration and bacteriological examination of small intestinal aspirates.
  • Treatment involves probiotics (Lactobacillus, Bifidobacterium) and, for severe cases, antibiotics such as vancomycin, metronidazole, aminoglycosides, amoxicillin-clavulanate, tetracycline, and second-generation cephalosporins, followed by probiotic restoration.

Impact:

  • Understanding SIBOS is crucial for managing chronic gastrointestinal disorders characterized by malabsorption and dysbiosis.
  • Accurate diagnosis and targeted treatment of SIBOS can prevent complications like vitamin deficiencies and systemic infections.
  • Effective management of SIBOS, combining antibiotics and probiotics, aims to restore intestinal homeostasis and improve patient outcomes.

Related Concept Videos

Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Histology of the Small Intestine01:27

Histology of the Small Intestine

The small intestine exhibits a unique histological structure that significantly enhances its function in digestion and nutrient absorption. These structures include circular folds, villi, and various specialized cells that collectively facilitate the digestion of food.
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...